Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRDN
3951
Guardian Pharmacy Services
GRDN
$2.5B
| $311K | ﹤0.01% |
+18,500
| New | +$312K |
|
3952
Ring Energy
REI
$315M
| $311K | ﹤0.01% |
194,186
+142,074
| +273% | +$254K |
|
3953
Everspin Technologies
MRAM
$341M
| $311K | ﹤0.01% |
52,654
+32,240
| +158% | +$187K |
|
|
NOAH
3954
Noah Holdings
NOAH
$580M
| $310K | ﹤0.01% |
25,136
| – | – |
|
3955
Wheels Up
UP
$208M
| $310K | ﹤0.01% |
6,397
+4,877
| +321% | +$238K |
|
3956
MainStreet Bancshares
MNSB
$164M
| $309K | ﹤0.01% |
16,759
+4,256
| +34% | +$73.5K |
|
3957
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.38B
| $309K | ﹤0.01% |
23,000
| – | – |
|
3958
eGain
EGAN
$187M
| $309K | ﹤0.01% |
60,513
+19,772
| +49% | +$127K |
|
3959
Sera Prognostics
SERA
$79.9M
| $308K | ﹤0.01% |
39,450
+30,093
| +322% | +$218K |
|
3960
EverCommerce
EVCM
$2.18B
| $307K | ﹤0.01% |
29,677
+22,360
| +306% | +$242K |
|
|
PLL
3961
DELISTED
Piedmont Lithium
PLL
| $306K | ﹤0.01% |
34,322
+17,569
| +105% | +$159K |
|
3962
Capital Bancorp
CBNK
$608M
| $306K | ﹤0.01% |
11,918
+8,918
| +297% | +$215K |
|
3963
Lakeland Industries
LAKE
$113M
| $306K | ﹤0.01% |
+15,234
| New | +$342K |
|
3964
Waterstone Financial
WSBF
$370M
| $306K | ﹤0.01% |
20,824
+14,737
| +242% | +$213K |
|
3965
Utah Medical Products
UTMD
$225M
| $306K | ﹤0.01% |
4,574
+3,118
| +214% | +$212K |
|
3966
LanzaTech
LNZA
$61.2M
| $306K | ﹤0.01% |
1,602
+1,223
| +323% | +$200K |
|
3967
AdvisorShares Pure US Cannabis ETF
MSOS
$858M
| $305K | ﹤0.01% |
42,602
+17,521
| +70% | +$124K |
|
|
AY
3968
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $305K | ﹤0.01% |
13,890
-56,444
| -80% | -$1.24M |
|
3969
Lexicon Pharmaceuticals
LXRX
$1.03B
| $304K | ﹤0.01% |
193,873
+154,436
| +392% | +$275K |
|
3970
Arteris
AIP
$1.38B
| $304K | ﹤0.01% |
39,396
+30,041
| +321% | +$232K |
|
3971
Jasper Therapeutics
JSPR
$21M
| $304K | ﹤0.01% |
16,146
+12,308
| +321% | +$245K |
|
|
ARTV
3972
Artiva Biotherapeutics
ARTV
$491M
| $303K | ﹤0.01% |
+19,616
| New | +$227K |
|
3973
W&T Offshore
WTI
$534M
| $303K | ﹤0.01% |
140,781
+107,045
| +317% | +$238K |
|
3974
Nautilus Biotechnolgy
NAUT
$124M
| $303K | ﹤0.01% |
106,174
+47,059
| +80% | +$122K |
|
|
LAR
3975
Lithium Argentina AG
LAR
$985M
| $301K | ﹤0.01% |
92,438
+21,388
| +30% | +$59.3K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.